- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05585216
The Efficacy of PRP Combined With Exercise to Treat Knee Osteoarthritisq
October 18, 2022 updated by: Hebei Medical University Third Hospital
The Efficacy of PRP Combined With Leg Swing and Quadriceps Strengthening Exercise to Treat Knee Osteoarthritis
Objective.
In this study, the investigators aimed to investigate the efficacy of combined a single platelet-rich plasma (PRP) and physical exercise (leg swing and quadriceps strengthening exercise) versus PRP and hyaluronic acid (HA) combination therapy.
Methods.
One hundred and six patients with grade Ⅱ-Ⅲ Knee osteoarthritis (KOA) according to the Kellgren-Lawrence classification were randomly divided into intra-articular injection of PRP combined with leg swing and quadriceps strengthening exercise (group A) and intra-articular combination injections of PRP and HA (group B).
Patients in group A received twice intra-articular injection of PRP (2 ml, 2 weeks apart) and regular leg swing and quadriceps strengthening exercise for 3 months.
Patients in group B received twice intra-articular combination injections of PRP (2 ml) and HA (2 ml) every 2 weeks.
The primary outcome measures were Visual Analogue Scale (VAS) and Western Ontario and McMaster Universities (WOMAC) score.
The second outcomes included single leg stance test (SLS) and functional activity by 2 minutes walking test (2MWT) and time up and go test (TUGT).
All outcomes were evaluated at baseline and after 1,3,6, and 12 months.
Study Overview
Status
Completed
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
120
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Hebei
-
Shijiazhuang, Hebei, China, 050000
- The Third Hospital of Hebei Medical University
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
40 years to 80 years (ADULT, OLDER_ADULT)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- patients aged ≥ 45 years old;
- KOA was diagnosed according to the American College of Rheumatology Classification Criteria;
- patients with the Kellgren-Lawrence grade (K-L grade) for KOA of Ⅰ-Ⅲ;
- a history of symptoms more than three month, and patients with independent mobility.
Exclusion Criteria:
- lower limb axial deviation large than 5° (valgus and varus knee);
- patients with diabetes mellitus, sever cardiovascular disease, immunosuppressive status, mental illness or other diseases than might affect the results;
- injections or other invasive treatments into the lower extremities were used in the past three months;
- patients willing to follow the doctor's recommendation for exercise training;
- patients with previous knee fracture or malignancy;
- patients with a previous history of hip or knee joint surgery;
- patients participating in hip or knee muscle strengthening in the past 3 months;
- patients did not complete the intervention strategies or regular follow-up.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: TRIPLE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
EXPERIMENTAL: PRP combined with leg swing and quadriceps strengthening exercise
Group A received twice intra-articular injection of platelet-rich plasma (2 ml, 2 weeks apart) and regular leg swing and quadriceps strengthening exercise for three months.
|
intra-articular combination injections of platelet-rich plasma and hyaluronic acid or intra-articular combination injections of PRP combined with leg swing and quadriceps strengthening exercise
|
|
ACTIVE_COMPARATOR: intra-articular combination injections of PRP and HA
Group B received twice intra-articular combination injections of PRP (2 ml) and HA (2 ml) every 2 weeks.
|
intra-articular combination injections of platelet-rich plasma and hyaluronic acid or intra-articular combination injections of PRP combined with leg swing and quadriceps strengthening exercise
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Visual Analogue Scale (VAS)
Time Frame: 12 months
|
Degree of knee pain during treatment
|
12 months
|
|
Western Ontario and McMaster Universities (WOMAC) score
Time Frame: 12 months
|
Severity of knee osteoarthritis
|
12 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
single leg stance test (SLS)
Time Frame: 12 months
|
Assess the patient's balance
|
12 months
|
|
2 minutes walking test (2MWT)
Time Frame: 12 months
|
Assess the patient's functional activity
|
12 months
|
|
time up and go test (TUGT)
Time Frame: 12 months
|
time up and go test (TUGT)
|
12 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (ACTUAL)
January 1, 2021
Primary Completion (ACTUAL)
August 31, 2021
Study Completion (ACTUAL)
October 1, 2021
Study Registration Dates
First Submitted
October 15, 2022
First Submitted That Met QC Criteria
October 15, 2022
First Posted (ACTUAL)
October 18, 2022
Study Record Updates
Last Update Posted (ACTUAL)
October 20, 2022
Last Update Submitted That Met QC Criteria
October 18, 2022
Last Verified
October 1, 2022
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- QIE001
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Knee Osteoarthritis
-
Istanbul University - CerrahpasaCompletedKnee Osteoarthritis | Knee Osteoarthritis (Knee OA)Turkey (Türkiye)
-
Edin MešanovićCompletedOsteoarthritis | Osteoarthritis of the Knee | Osteoarthritis of Knee | Osteoarthritis of the Knees | Osteoarthritis (OA) of the Knee | Osteoarthritis Knee | Osteoarthritis in the Knee | Osteoarthritis of Knee JointBosnia and Herzegovina
-
Golden Jubilee National HospitalJohnson & Johnson; DePuy OrthopaedicsNot yet recruitingOsteoarthritis | Knee Osteoarthritis | Osteoarthritis (OA) | Osteo Arthritis | Osteoarthritis in the Knee | Osteoarthritis (Knee) | Osteo Arthritis of the KneeUnited Kingdom
-
Dr. David WassersteinSunnybrook Research InstituteRecruitingKnee Osteoarthritis (Knee OA) | Knee Osteoarthritis (OA)Canada
-
LifeBridge HealthMicroPort Orthopedics Inc.; Rubin Institute for Advanced OrthopedicsRecruitingKnee Osteoarthritis | Osteoarthritis, Knee | Knee Pain Chronic | Arthropathy of Knee Joint | Knee Disease | Osteoarthritis Knees Both | Osteoarthritis Knee Left | Osteoarthritis Knee RightUnited States
-
Lucas R. Cusumano, MDNot yet recruitingKnee Osteoarthritis | Knee Discomfort | Knee Pain Chronic | Knee Swelling PainUnited States
-
Emory UniversityVertex Pharmaceuticals IncorporatedNot yet recruitingKnee Osteoarthritis | Knee ArthritisUnited States
-
VA Office of Research and DevelopmentNot yet recruitingKnee Osteoarthritis (Knee OA)United States
-
The Hong Kong Polytechnic UniversityChinese University of Hong Kong; Zhujiang HospitalNot yet recruitingKnee Osteoarthritis (Knee OA)
-
University of MiamiNot yet recruiting
Clinical Trials on platelet-rich plasma
-
Stanford UniversityPartnership for Clean CompetitionCompletedRheumatic Diseases | TendinopathyUnited States
-
University of UtahRecruitingTendinopathy | Osteoarthritis (OA) | Elbow Osteoarthritis | Osteoarthritis (OA) of the Knee | Epicondylitis of the Elbow | Osteoarthritis Ankle | Plantar Fasciitis of Both Feet | Osteoarthritis (OA) of the Shoulder | Osteoarthritis (OA) of the HipUnited States
-
Genesis Athens ClinicNational and Kapodistrian University of AthensRecruitingMenopause, Premature | Menopausal Syndrome | Premature Ovarian Failure | Ovarian Failure, Premature | Menopause Related ConditionsGreece
-
VivaTech International, Inc.RecruitingOsteoarthritisUnited States
-
Kafrelsheikh UniversityCompletedFemale Stress Urinary IncontinenceEgypt
-
Matthew PingreeTerminatedLumbar SpondylosisUnited States
-
Nasser Institute For Research and TreatmentCompletedPlatelet Rich Fibrin | Platelet Rich Plasma Injection | Degenerative Temporomandibular JointEgypt
-
Damascus UniversityCompletedBone ResorptionSyrian Arab Republic
-
Cardenal Herrera UniversityCompletedCarpal Tunnel SyndromeSpain
-
Peking University Third HospitalCompleted